Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine + Rivastigmine in Mild to Moderate Alzheimer's Disease
NCT06702124Phase 3Recruiting
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in Alzheimer's disease (AD), sponsored by Fondazione Santa Lucia IRCCS. Started Dec 2023; status: recruiting.
02
Drugs
rotigotine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06702124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702124.